The brain mineralocorticoid receptor and stress resilience

Psychoneuroendocrinology

Volumn 52, Issue 1, 2015, Pages 92-110

  ter Heegde, Freija ^a   De Rijk, Roel H ^b,c   Vinkers, Christiaan H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Department of Clinical Psychology ^*  (Netherlands)

Author keywords

Adversity; Childhood maltreatment; Depression; HPA axis; Mineralocorticoid receptor; NR3C2; Stress vulnerability; Trauma

Indexed keywords

AMITRIPTYLINE; BUSPIRONE; CANRENOIC ACID; CITALOPRAM; DESIPRAMINE; FLUDROCORTISONE; FLUOXETINE; METYRAPONE; MINERALOCORTICOID RECEPTOR; MOCLOBEMIDE; SPIRONOLACTONE; VENLAFAXINE;

BIPOLAR DISORDER; COPING BEHAVIOR; DEPRESSION; FEAR; GENE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MEMORY; MENTAL DISEASE; NEUROMODULATION; NONHUMAN; NR3C2 GENE; POSTTRAUMATIC STRESS DISORDER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SCHIZOPHRENIA; SEX DIFFERENCE; STRESS; SUICIDE; ANIMAL; BRAIN; MENTAL STRESS; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN; HUMANS; RECEPTORS, MINERALOCORTICOID; RESILIENCE, PSYCHOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84922675123     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.10.022     Document Type: Review

References (158)

1. Arp J.M., ter Horst J.P., Kanatsou S., Fernández G., Joëls M., Krugers H.J., Oitzl M.S. Mineralocorticoid receptors guide spatial and stimulus-response learning in mice. PLoS ONE 2014, 9:e86236. 10.1371/journal.pone.0086236
2. Arriza J.L., Simerly R.B., Swanson L.W., Evans R.M. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1988, 1:887-900. 10.1016/0896-6273(88)90136-5
3. Arvat E., Maccagno B., Giordano R., Pellegrino M., Broglio F., Gianotti L., Maccario M., Camanni F., Ghigo E. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans. J. Clin. Endocrinol. Metab. 2001, 86:3176-3181. 10.1210/jcem.86.7.7663
4. Atkinson H.C., Wood S.A., Castrique E.S., Kershaw Y.M., Wiles C.C.R., Lightman S.L. Corticosteroids mediate fast feedback of the rat hypothalamic-pituitary-adrenal axis via the mineralocorticoid receptor. Am. J. Physiol. Endocrinol. Metab. 2008, 294:E1011-E1022. 10.1152/ajpendo.00721.2007
5. Avital A., Segal M., Richter-Levin G. Contrasting roles of corticosteroid receptors in hippocampal plasticity. J. Neurosci. 2006, 26:9130-9134. 10.1523/JNEUROSCI.1628-06.2006
6. Baes C., von W., Martins C.M.S., de Carvalho Tofoli S.M., Juruena M.F. Early life stress in depressive patients: HPA axis response to GR and MR agonist. Front. Psychiatry 2014, 5:2. 10.3389/fpsyt.2014.00002
7. Barrett Mueller K., Lu Q., Mohammad N., Luu V., McCurley A., Williams G., Adler G., Karas R., Jaffe I. Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function. Endocrinology 2014, (July):en2.
8. Berardelli R., Karamouzis I., D'Angelo V., Zichi C., Fussotto B., Giordano R., Ghigo E., Arvat E. Role of mineralocorticoid receptors on the hypothalamus-pituitary-adrenal axis in humans. Endocrine 2013, 43:51-58. 10.1007/s12020-012-9750-8
9. Berardelli R., Karamouzis I., Marinazzo E., Prats E., Picu A., Giordano R., Ghigo E., Arvat E. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans. Eur. J. Endocrinol. 2010, 162:1067-1074. 10.1530/EJE-09-1076
10. Berger S., Wolfer D.P., Selbach O., Alter H., Erdmann G., Reichardt H.M., Chepkova A.N., Welzl H., Haas H.L., Lipp H.-P., Schütz G. Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:195-200. 10.1073/pnas.0503878102
11. Bjartmar L., Johansson I.M., Marcusson J., Ross S.B., Seckl J.R., Olsson T. Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat. Psychopharmacology (Berl.) 2000, 151:7-12. 10.1007/s002130000468
12. Bogdan R., Perlis R.H., Fagerness J., Pizzagalli D.A. The impact of mineralocorticoid receptor ISO/VAL genotype (rs5522) and stress on reward learning. Genes Brain. Behav. 2010, 9:658-667. 10.1111/j.1601-183X.2010.00600.x
13. Bogdan R., Williamson D.E., Hariri A.R. Mineralocorticoid receptor Iso/Val (rs5522) genotype moderates the association between previous childhood emotional neglect and amygdala reactivity. Am. J. Psychiatry 2012, 169:515-522.
14. Bouma E.M.C., Riese H., Nolte I.M., Oosterom E., Verhulst F.C., Ormel J., Oldehinkel A.J. No associations between single nucleotide polymorphisms in corticoid receptor genes and heart rate and cortisol responses to a standardized social stress test in adolescents: the TRAILS study. Behav. Genet. 2011, 41:253-261. 10.1007/s10519-010-9385-6
15. Bradbury M.J., Akana S.F., Cascio C.S., Levin N., Jacobson L., Dallman M.F. Regulation of basal ACTH secretion by corticosterone is mediated by both type I (MR) and type II (GR) receptors in rat brain. J. Steroid Biochem. Mol. Biol. 1991, 40:133-142. 10.1016/0960-0760(91)90176-6
16. Brinks V., Berger S., Gass P., de Kloet E.R., Oitzl M.S. Mineralocorticoid receptors in control of emotional arousal and fear memory. Horm. Behav. 2009, 56:232-238. 10.1016/j.yhbeh.2009.05.003
17. Buckley T.M., Mullen B.C., Schatzberg A.F. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls. Psychoneuroendocrinology 2007, 32:859-864. 10.1016/j.psyneuen.2007.05.016
18. Carey M.P., Deterd C.H., de Koning J., Helmerhorst F., de Kloet E.R. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J. Endocrinol. 1995, 144:311-321. 10.1677/joe.0.1440311
19. Carey R.M., Padia S.H. Physiology and regulation of the renin-angiotensin-aldosterone system. Textbook of Nephro-Endocrinology 2008, 147-165. 10.1016/B978-0-12-373870-7.00012-0.
20. Castrén M., Patchev V.K., Almeida O.F., Holsboer F., Trapp T., Castrén E. Regulation of rat mineralocorticoid receptor expression in neurons by progesterone. Endocrinology 1995, 136:3800-3806.
21. Chang Y.T., Chen Y.C., Wu C.W., Yu L., Chen H.I., Jen C.J., Kuo Y.M. Glucocorticoid signaling and exercise-induced downregulation of the mineralocorticoid receptor in the induction of adult mouse dentate neurogenesis by treadmill running. Psychoneuroendocrinology 2008, 33:1173-1182. 10.1016/j.psyneuen.2008.05.014
22. Chauveau F., Tronche C., Piérard C., Liscia P., Drouet I., Coutan M., Béracochéa D. Rapid stress-induced corticosterone rise in the hippocampus reverses serial memory retrieval pattern. Hippocampus 2010, 20:196-207. 10.1002/hipo.20605
23. Cole M.A., Kalman B.A., Pace T.W.W., Topczewski F., Lowrey M.J., Spencer R.L. Selective blockade of the mineralocorticoid receptor impairs hypothalamic-pituitary-adrenal axis expression of habituation. J. Neuroendocrinol. 2000, 12:1034-1042. 10.1046/j.1365-2826.2000.00555.x
24. Cornelisse S., Joëls M., Smeets T. A randomized trial on mineralocorticoid receptor blockade in men: effects on stress responses, selective attention, and memory. Neuropsychopharmacology 2011, 36:2720-2728. 10.1038/npp.2011.162
25. Crochemore C., Lu J., Wu Y., Liposits Z., Sousa N., Holsboer F., Almeida O.F.X. Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol. Psychiatry 2005, 10:790-798. 10.1038/sj.mp.4001679
26. Cyranowski J.M., Frank E., Young E., Shear M.K. Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model. Arch. Gen. Psychiatry 2000, 57:21-27. 10.1001/archpsyc.57.1.21
27. de Kloet E.R., Reul J.M. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 1987, 12:83-105. 10.1016/0306-4530(87)90040-0
28. de Kloet E.R., Oitzl M.S., Joels M. Stress and cognition: are corticosteroids good or bad guys?. Trends Neurosci. 1999, 22:422-426. 10.1016/S0166-2236(99)01438-1
29. de Kloet E.R., Joëls M., Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6:463-475. 10.1038/nrn1683
30. de Kloet E.R., DeRijk R.H., Meijer O.C. Therapy insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression?. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3:168-179. 10.1038/ncpendmet0403
31. de Kloet E.R. Functional profile of the binary brain corticosteroid receptor system: mediating, multitasking, coordinating, integrating. Eur. J. Pharmacol. 2013, 19:53-62. 10.1016/j.ejphar.2013.04.053
32. DeRijk R.H., Wüst S., Meijer O.C., Zennaro M.-C., Federenko I.S., Hellhammer D.H., Giacchetti G., Vreugdenhil E., Zitman F.G., de Kloet E.R. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J. Clin. Endocrinol. Metab. 2006, 91:5083-5089. 10.1210/jc.2006-0915
33. DeRijk R.H., van Leeuwen N., Klok M.D., Zitman F.G. Corticosteroid receptor-gene variants: modulators of the stress-response and implications for mental health. Eur. J. Pharmacol. 2008, 585:492-501. 10.1016/j.ejphar.2008.03.012
34. DeRijk R.H., de Kloet E.R., Zitman F.G., van Leeuwen N. Mineralocorticoid receptor gene variants as determinants of HPA axis regulation and behavior. Endocr. Dev. 2011, 20:137-148. 10.1159/000321235
35. Deuschle M., Weber B., Colla M., Müller M., Kniest A., Heuser I. Mineralocorticoid receptor also modulates basal activity of hypothalamus-pituitary-adrenocortical system in humans. Neuroendocrinology 1998, 68:355-360. 10.1159/000054384
36. Dorey R., Piérard C., Shinkaruk S., Tronche C., Chauveau F., Baudonnat M., Béracochéa D. Membrane mineralocorticoid but not glucocorticoid receptors of the dorsal hippocampus mediate the rapid effects of corticosterone on memory retrieval. Neuropsychopharmacology 2011, 36:2639-2649. 10.1038/npp.2011.152
37. Ferguson D., Sapolsky R. Mineralocorticoid receptor overexpression differentially modulates specific phases of spatial and nonspatial memory. J. Neurosci. 2007, 27:8046-8052. 10.1523/JNEUROSCI.1187-07.2007
38. Fernandez-Guasti A., Fiedler J.L., Herrera L., Handa R.J. Sex, stress, and mood disorders: at the intersection of adrenal and gonadal hormones. Horm. Metab. Res. 2012, 44:607-618. 10.1055/s-0032-1312592
39. Ferrari P. The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension. Biochim. Biophys. Acta 2010, 1802:1178-1187. 10.1016/j.bbadis.2009.10.017
40. Gekle M., Bretschneider M., Meinel S., Ruhs S., Grossmann C. Rapid MR trafficking. Steroids 2013, 81:103-108. 10.1016/j.steroids.2013.10.016
41. Gesing A., Bilang-Bleuel A., Droste S.K., Linthorst A.C., Holsboer F., Reul J.M. Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone. J. Neurosci. 2001, 21:4822-4829.
42. Giordano R., Bo M., Pellegrino M., Vezzari M., Baldi M., Picu A., Balbo M., Bonelli L., Migliaretti G., Ghigo E., Arvat E. Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade. J. Clin. Endocrinol. Metab. 2005, 90:5656-5662. 10.1210/jc.2005-0105
43. Groeneweg F.L., Karst H., de Kloet E.R., Joëls M. Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling. Mol. Cell. Endocrinol. 2012, 250:299-309. 10.1016/j.mce.2011.06.020
44. Grossmann C., Scholz T., Rochel M., Bumke-Vogt C., Oelkers W., Pfeiffer A.F.H., Diederich S., Bähr V. Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur. J. Endocrinol. 2004, 151:397-406. 10.1530/eje.0.1510397
45. Harris A.P., Holmes M.C., de Kloet E.R., Chapman K.E., Seckl J.R. Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour. Psychoneuroendocrinology 2013, 38:648-658. 10.1016/j.psyneuen.2012.08.007
46. Heim C., Newport D.J., Mletzko T., Miller A.H., Nemeroff C.B. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 2008, 33:693-710. 10.1016/j.psyneuen.2008.03.008
47. Heuser I., Deuschle M., Weber A., Kniest A., Ziegler C., Weber B., Colla M. The role of mineralocorticoid receptors in the circadian activity of the human hypothalamus-pituitary-adrenal system: effect of age. Neurobiol. Aging 2000, 21:585-589. 10.1016/S0197-4580(00)00145-7
48. Hlavacova N., Jezova D. Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior. Horm. Behav. 2008, 54:90-97. 10.1016/j.yhbeh.2008.02.004
49. Hlavacova N., Wes P.D., Ondrejcakova M., Flynn M.E., Poundstone P.K., Babic S., Murck H., Jezova D. Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder. Int. J. Neuropsychopharmacol. 2012, 15:247-265. 10.1017/S1461145711000368
50. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J. Psychiatr. Res. 1999, 33:181-214. 10.1016/S0022-3956(98)90056-5
51. Ising M., Depping A.M., Siebertz A., Lucae S., Unschuld P.G., Kloiber S., Horstmann S., Uhr M., Muller-Myhsok B., Holsboer F. Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur. J. Neurosci. 2008, 28:389-398. pii:EJN6332. 10.1111/j.1460-9568.2008.06332.x
52. Jahn H., Schick M., Kiefer F., Kellner M., Yassouridis A., Wiedemann K. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch. Gen. Psychiatry 2004, 61:1235-1244. pii:61/12/1235. 10.1001/archpsyc.61.12.1235
53. Joëls M., de Kloet E.R. Mineralocorticoid receptor-mediated changes in membrane properties of rat CA1 pyramidal neurons in vitro. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:4495-4498.
54. Joëls M., Hesen W., de Kloet E.R. Mineralocorticoid hormones suppress serotonin-induced hyperpolarization of rat hippocampal CA1 neurons. J. Neurosci. 1991, 11:2288-2294.
55. Joëls M., Pu Z., Wiegert O., Oitzl M.S., Krugers H.J. Learning under stress: how does it work?. Trends Cogn. Sci. 2006, 10:152-158. 10.1016/j.tics.2006.02.002
56. Joëls M., Karst H., DeRijk R., de Kloet E.R. The coming out of the brain mineralocorticoid receptor. Trends Neurosci. 2008, 31:1-7. 10.1016/j.tins.2007.10.005
57. Joëls M., Baram T.Z., Joëls M. The neuro-symphony of stress. Nat. Rev. Neurosci. 2009, 10:459-466.
58. Joëls M., Sarabdjitsingh R.A., Karst H. Unraveling the time domains of corticosteroid hormone influences on brain activity: rapid, slow, and chronic modes. Pharmacol. Rev. 2012, 64:901-938.
59. Juruena M.F., Cleare A.J., Papadopoulos A.S., Poon L., Lightman S., Pariante C.M. Different responses to dexamethasone and prednisolone in the same depressed patients. Psychopharmacology (Berl.) 2006, 189:225-235. 10.1007/s00213-006-0555-4
60. Juruena M.F., Pariante C.M., Papadopoulos A.S., Poon L., Lightman S., Cleare A.J. Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance. Br. J. Psychiatry 2009, 194:342-349. 10.1192/bjp.bp.108.050278
61. Juruena M.F., Cleare A.J., Papadopoulos A.S., Poon L., Lightman S., Pariante C.M. The prednisolone suppression test in depression: dose-response and changes with antidepressant treatment. Psychoneuroendocrinology 2010, 35:1486-1491. 10.1016/j.psyneuen.2010.04.016
62. Juruena M.F., Pariante C.M., Papadopoulos A.S., Poon L., Lightman S., Cleare A.J. The role of mineralocorticoid receptor function in treatment-resistant depression. J. Psychopharmacol. 2013, 27:1169-1179. 1169-79. 10.1177/0269881113499205
63. Juster R.P., McEwen B.S., Lupien S.J. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci. Biobehav. Rev. 2010, 35:2-16. 10.1016/j.neubiorev.2009.10.002
64. Karandrea D., Kittas C., Kitraki E. Contribution of sex and cellular context in the regulation of brain corticosteroid receptors following restraint stress. Neuroendocrinology 2000, 71:343-353. 10.1159/000054555
65. Karst H., Berger S., Erdmann G., Schutz G., Joels M. Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:14449-14454.
66. Karst H., Berger S., Turiault M., Tronche F., Schutz G., Joels M. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:19204-19207. 10.1073/pnas.0507572102
67. Karten Y.J.G., Nair S.M., van Essen L., Sibug R., Joëls M. Long-term exposure to high corticosterone levels attenuates serotonin responses in rat hippocampal CA1 neurons. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:13456-13461. 10.1073/pnas.96.23.13456
68. Kellner M., Wiedemann K. Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapy. Eur. J. Pharmacol. 2008, 583:372-378. 10.1016/j.ejphar.2007.07.072
69. Khaksari M., Rashidy-Pour A., Vafaei A.A. Central mineralocorticoid receptors are indispensable for corticosterone-induced impairment of memory retrieval in rats. Neuroscience 2007, 149:729-738. 10.1016/j.neuroscience.2007.08.016
70. Kitraki E., Kremmyda O., Youlatos D., Alexis M.N., Kittas C. Gender-dependent alterations in corticosteroid receptor status and spatial performance following 21 days of restraint stress. Neuroscience 2004, 125:47-55. 10.1016/j.neuroscience.2003.12.024
71. Klok M.D., Alt S.R., Irurzun Lafitte A.J., Turner J.D., Lakke E.A., Huitinga I., Muller C.P., Zitman F.G., de Kloet E.R., Derijk R.H. Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder. J. Psychiatr. Res. 2011, 45:871-878. 10.1016/j.jpsychires.2010.12.002
72. Klok M.D., Giltay E.J., Van der Does A.J., Geleijnse J.M., Antypa N., Penninx B.W., de Geus E.J., Willemsen G., Boomsma D.I., van Leeuwen N., Zitman F.G., de Kloet E.R., DeRijk R.H. A common and functional mineralocorticoid receptor haplotype enhances optimism and protects against depression in females. Transl. Psychiatry 2011, 1:e62. 10.1038/tp.2011.59
73. Klok M.D., Vreeburg S.A., Penninx B.W., Zitman F.G., de Kloet E.R., DeRijk R.H. Common functional mineralocorticoid receptor polymorphisms modulate the cortisol awakening response: interaction with SSRIs. Psychoneuroendocrinology 2011, 36:484-494. 10.1016/j.psyneuen.2010.07.024
74. Kruk M.R., Halász J., Meelis W., Haller J. Fast positive feedback between the adrenocortical stress response and a brain mechanism involved in aggressive behavior. Behav. Neurosci. 2004, 118:1062-1070. 10.1037/0735-7044.118.5.1062
75. Kruk M.R., Haller J., Meelis W., de Kloet E.R. Mineralocorticoid receptor blockade during a rat's first violent encounter inhibits its subsequent propensity for violence. Behav. Neurosci. 2013, 127:505-514. 10.1037/a0033553
76. Kudielka B.M., Kirschbaum C. Sex differences in HPA axis responses to stress: a review. Biol. Psychol. 2005, 69:113-132.
77. Kuningas M., De Rijk R.H., Westendorp R.G.J., Jolles J., Slagboom P.E., van Heemst D. Mental performance in old age dependent on cortisol and genetic variance in the mineralocorticoid and glucocorticoid receptors. Neuropsychopharmacology 2007, 32:1295-1301. 10.1038/sj.npp.1301260
78. Lai M., Horsburgh K., Bae S.E., Carter R.N., Stenvers D.J., Fowler J.H., Yau J.L., Gomez-Sanchez C.E., Holmes M.C., Kenyon C.J., Seckl J.R., Macleod M.R. Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia. Eur. J. Neurosci. 2007, 25:1832-1842. 10.1111/j.1460-9568.2007.05427.x
79. Lembke A., Gomez R., Tenakoon L., Keller J., Cohen G., Williams G.H., Kraemer F.B., Schatzberg A.F. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. Psychoneuroendocrinology 2013, 38:115-121. 10.1016/j.psyneuen.2012.05.006
80. Llorente R., Miguel-Blanco C., Aisa B., Lachize S., Borcel E., Meijer O.C., Ramirez M.J., de Kloet E.R., Viveros M.P. Long term sex-dependent psychoneuroendocrine effects of maternal deprivation and juvenile unpredictable stress in rats. J. Neuroendocrinol. 2011, 23:329-344. 10.1111/j.1365-2826.2011.02109.x
81. Lopez J.F., Chalmers D.T., Little K.Y., Watson S.J. Regulation of serotonin(1A), glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol. Psychiatry 1998, 43:547-573. 10.1016/S0006-3223(97)00484-8
82. Macleod M.R., Johansson I.-M., Söderström I., Lai M., Gidö G., Wieloch T., Seckl J.R., Olsson T. Mineralocorticoid receptor expression and increased survival following neuronal injury. Eur. J. Neurosci. 2003, 17:1549-1555. 10.1046/j.1460-9568.2003.02587.x
83. Marissal-Arvy N., Lombès M., Petterson J., Moisan M.P., Mormède P. Gain of function mutation in the mineralocorticoid receptor of the Brown Norway rat. J. Biol. Chem. 2004, 279:39232-39239.
84. Marissal-Arvy N., Ribot E., Sarrieau A., Mormède P. Is the mineralocorticoid receptor in Brown Norway rats constitutively active?. J. Neuroendocrinol. 2000, 12:576-588.
85. Martinerie L., Munier M., Le Menuet D., Meduri G., Viengchareun S., Lombès M. The mineralocorticoid signaling pathway throughout development: expression, regulation and pathophysiological implications. Biochimie 2013, 95:148-157. 10.1016/j.biochi.2012.09.030
86. Marzolla V., Armani A., Zennaro M.C., Cinti F., Mammi C., Fabbri A., Rosano G.M.C., Caprio M. The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism. Mol. Cell. Endocrinol. 2012, 24:281-288. 10.1016/j.mce.2011.09.011
87. McEwen B.S. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann. N. Y. Acad. Sci. 2004, 1032:1-7. 10.1196/annals.1314.001
88. Medina A., Seasholtz A.F., Sharma V., Burke S., Bunney W., Myers R.M., Schatzberg A., Akil H., Watson S.J. Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder. J. Psychiatr. Res. 2013, 47:307-314. 10.1016/j.jpsychires.2012.11.002
89. Meinel S., Gekle M., Grossmann C. Mineralocorticoid receptor signaling: crosstalk with membrane receptors and other modulators. Steroids 2014, pii:S0039-128X(14)00130-5 [Epub ahead of print]. 10.1016/j.steroids.2014.05.017.
90. Mikics E., Barsy B., Barsvári B., Haller J. Behavioral specificity of non-genomic glucocorticoid effects in rats: effects on risk assessment in the elevated plus-maze and the open-field. Horm. Behav. 2005, 48:152-162.
91. Mitra R., Ferguson D., Sapolsky R.M. Mineralocorticoid receptor overexpression in basolateral amygdala reduces corticosterone secretion and anxiety. Biol. Psychiatry 2009, 66:686-690. 10.1016/j.biopsych.2009.04.016
92. Muhtz C., Zyriax B.C., Bondy B., Windler E., Otte C. Association of a common mineralocorticoid receptor gene polymorphism with salivary cortisol in healthy adults. Psychoneuroendocrinology 2011, 36:298-301. 10.1016/j.psyneuen.2010.08.003
93. Munier M., Law F., Meduri G., Le Menuet D., Lombès M. Mineralocorticoid receptor overexpression facilitates differentiation and promotes survival of embryonic stem cell-derived neurons. Endocrinology 2012, 153:1330-1340. 10.1210/en.2011-1436
94. Murck H., Schüssler P., Steiger A. Renin-angiotensin-aldosterone system: the forgotten stress hormone system: relationship to depression and sleep. Pharmacopsychiatry 2012, 39:23-29. 10.1055/s-0031-1291346
95. Oitzl M.S., de Kloet E.R. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav. Neurosci. 1992, 106:62-71. 10.1037/0735-7044.106.1.62
96. Oitzl M.S., Fluttert M., de Kloet E.R. The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors. Eur. J. Neurosci. 1994, 6:1072-1079. 10.1111/j.1460-9568.1994.tb00604.x
97. Otte C., Wingenfeld K., Kuehl L.K., Kaczmarczyk M., Richter S., Quante A., Regen F., Bajbouj M., Zimmermann-Viehoff F., Wiedemann K., Hinkelmann K. Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals. Neuropsychopharmacology 2014, [Epub ahead of print]. 10.1038/npp.2014.181 2014.
98. Otte C., Hinkelmann K., Moritz S., Yassouridis A., Jahn H., Wiedemann K., Kellner M. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study. J. Psychiatr. Res. 2010, 44:339-346. 10.1016/j.jpsychires.2009.10.006
99. Otte C., Jahn H., Yassouridis A., Arlt J., Stober N., Maass P., Wiedemann K., Kellner M. The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone. Life Sci. 2003, 73:1835-1845. 10.1016/S0024-3205(03)00513-7
100. Otte C., Moritz S., Yassouridis A., Koop M., Madrischewski A.M., Wiedemann K., Kellner M. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition. Neuropsychopharmacology 2007, 32:232-238. 10.1038/sj.npp.1301217
101. Otte C., Muhtz C., Daneshkhah S., Yassouridis A., Kiefer F., Wiedemann K., Kellner M. Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone. Biol. Psychiatry 2006, 60:784-787. 10.1016/j.biopsych.2006.01.014
102. Otte C., Yassouridis A., Jahn H., Maass P., Stober N., Wiedemann K., Kellner M. Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans. J. Gerontol. Ser. A: Biol. Sci. Med. Sci. 2003, 58:B900-B905.
103. Pascual-Le Tallec L., Demange C., Lombès M. Human mineralocorticoid receptor A and B protein forms produced by alternative translation sites display different transcriptional activities. Eur. J. Endocrinol. 2004, 150:585-590. 10.1530/eje.0.1500585
104. Pascual-Le Tallec L., Lombès M. The mineralocorticoid receptor: a journey exploring its diversity and specificity of action. Mol. Endocrinol. 2005, 19:2211-2221. 10.1210/me.2005-0089
105. Patel P.D., Lopez J.F., Lyons D.M., Burke S., Wallace M., Schatzberg A.F. Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J. Psychiatr. Res. 2001, 34:383-392.
106. Perlman W.R., Webster M.J., Herman M.M., Kleinman J.E., Weickert C.S. Age-related differences in glucocorticoid receptor mRNA levels in the human brain. Neurobiol. Aging 2007, 28:447-458. 10.1016/j.neurobiolaging.2006.01.010
107. Piccinelli M., Wilkinson G. Gender differences in depression. Critical review. Br. J. Psychiatry 2000, 177:486-492. 10.1192/bjp.177.6.486
108. Prager E.M., Brielmaier J., Bergstrom H.C., McGuire J., Johnson L.R. Localization of mineralocorticoid receptors at mammalian synapses. PLoS ONE 2010, 5:e14344. 10.1371/journal.pone.0014344
109. Pryce C.R. Postnatal ontogeny of expression of the corticosteroid receptor genes in mammalian brains: inter-species and intra-species differences. Brain Res. Rev. 2008, 57:596-605. 10.1016/j.brainresrev.2007.08.005
110. Qi X.-R., Kamphuis W., Wang S., Wang Q., Lucassen P.J., Zhou J.-N., Swaab D.F. Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients. Psychoneuroendocrinology 2013, 38:863-870. 10.1016/j.psyneuen.2012.09.014
111. Qiu S., Champagne D.L., Peters M., Catania E.H., Weeber E.J., Levitt P., Pimenta A.F. Loss of limbic system-associated membrane protein leads to reduced hippocampal mineralocorticoid receptor expression, impaired synaptic plasticity, and spatial memory deficit. Biol. Psychiatry 2010, 68:197-204. 10.1016/j.biopsych.2010.02.013
112. Quinkler M., Meyer B., Bumke-Vogt C., Grossmann C., Gruber U., Oelkers W., Diederich S., Bahr V. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor. Eur. J. Endocrinol. 2002, 146:789-799. 10.1530/eje.0.1460789
113. Rafatian N., Westcott K.V., White R.A., Leenen F.H. Cardiac macrophages and apoptosis after myocardial infarction: effects of central MR blockade. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2014, 307:R879-R887. 10.1152/ajpregu.00075.2014
114. Ratka A., Sutanto W., Bloemers M., de Kloet E.R. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 1989, 50:117-123. 10.1159/000125210
115. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117:2505-2511. 10.1210/endo-117-6-2505
116. Reul J.M., Gesing A., Droste S., Stec I.S., Weber A., Bachmann C., Bilang-Bleuel A., Holsboer F., Linthorst A.C. The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur. J. Pharmacol. 2000, 405:235-249.
117. Reul J.M., Labeur M.S., Grigoriadis D.E., De Souza E.B., Holsboer F. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology 1994, 60:509-519. 10.1159/000126788
118. Reul J.M.H.M., Rothuizen J., de Kloet E.R. Age-related changes in the dog hypothalamic-pituitary-adrenocortical system: neuroendocrine activity and corticosteroid receptors. J. Steroid Biochem. Mol. Biol. 1991, 40:63-69. 10.1016/0960-0760(91)90168-5
119. Rickard A.J., Morgan J., Tesch G., Funder J.W., Fuller P.J., Young M.J. Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure. Hypertension 2009, 54:537-543. 10.1161/HYPERTENSIONAHA.109.131110
120. Rothuizen J., Reul J.M., van Sluijs F.J., Mol J.A., Rijnberk A., de Kloet E.R. Increased neuroendocrine reactivity and decreased brain mineralocorticoid receptor-binding capacity in aged dogs. Endocrinology 1993, 132:161-168. 10.1210/en.132.1.161
121. Rozeboom A.M., Akil H., Seasholtz A.F. Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:4688-4693. 10.1073/pnas.0606067104
122. Rupprecht R., Reul J.M., van Steensel B., Spengler D., Söder M., Berning B., Holsboer F., Damm K. Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur. J. Pharmacol. 1993, 247:145-154.
123. Schwabe L., Schächinger H., de Kloet E.R., Oitzl M.S. Corticosteroids operate as a switch between memory systems. J. Cogn. Neurosci. 2010, 22:1362-1372. 10.1162/jocn.2009.21278
124. Schwabe L., Joëls M., Roozendaal B., Wolf O.T., Oitzl M.S. Stress effects on memory: an update and integration. Neurosci. Biobehav. Rev. 2012, 36:1740-1749. 10.1016/j.neubiorev.2011.07.002
125. Schwabe L., Höffken O., Tegenthoff M., Wolf O.T. Stress-induced enhancement of response inhibition depends on mineralocorticoid receptor activation. Psychoneuroendocrinology 2013, 38:2319-2326. 10.1016/j.psyneuen.2013.05.001
126. Schwabe L., Tegenthoff M., Höffken O., Wolf O.T. Mineralocorticoid receptor blockade prevents stress-induced modulation of multiple memory systems in the human brain. Biol. Psychiatry 2013, 74:801-808. 10.1016/j.biopsych.2013.06.001
127. Seckl J.R., Dickson K.L., Yates C., Fink G. Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus. Brain Res. 1991, 561:332-337. 10.1016/0006-8993(91)91612-5
128. Seckl J.R., Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology 1992, 55:621-626.
129. Spijker A.T., Van Rossum E.F.C. Glucocorticoid sensitivity in mood disorders. Neuroendocrinology 2012, 95:179-186. 10.1159/000329846
130. Tasker J.G., Di S., Malcher-Lopes R. Minireview: rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology 2006, 147:5549-5556. 10.1210/en.2006-0981
131. Ter Horst J.P., Carobrez A.P., van der Mark M.H., de Kloet E.R., Oitzl M.S. Sex differences in fear memory and extinction of mice with forebrain-specific disruption of the mineralocorticoid receptor. Eur. J. Neurosci. 2012, 36:3096-3102. 10.1111/j.1460-9568.2012.08237.x.
132. Ter Horst J.P., van der Mark M.H., Arp M., Berger S., de Kloet E.R., Oitzl M.S. Stress or no stress: mineralocorticoid receptors in the forebrain regulate behavioral adaptation. Neurobiol. Learn. Mem. 2012, 98:33-40. 10.1016/j.nlm.2012.04.006
133. Ter Horst J.P., Kentrop J., Arp M., Hubens C.J., de Kloet E.R., Oitzl M.S. Spatial learning of female mice: a role of the mineralocorticoid receptor during stress and the estrous cycle. Front. Behav. Neurosci. 2013, 7:56. 10.3389/fnbeh.2013.00056
134. Turner B.B. Sex difference in glucocorticoid binding in rat pituitary is estrogen dependent. Life Sci. 1990, 46:1399-1406. 10.1016/0024-3205(90)90340-W
135. Van Eekelen J.A., Rots N.Y., Sutanto W., Oitzl M.S., de Kloet E.R. Brain corticosteroid receptor gene expression and neuroendocrine dynamics during aging. J. Steroid Biochem. Mol. Biol. 1991, 40:679-683. 10.1016/0960-0760(91)90290-L
136. van Leeuwen N. Mineralocorticoid receptor gene variants; Implications for stress, blood pressure and personality 2010, Thesis, Leiden University.
137. van Leeuwen N., Kumsta R., Entringer S., de Kloet E.R., Zitman F.G., Derijk R.H., Wu S., van Leeuwen N., de Kloet E.R., Wust S. Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone. Psychoneuroendocrinology 2010, 35:339-349. 10.1016/j.psyneuen.2009.07.006
138. van Leeuwen N., Kumsta R., Entringer S., de Kloet E.R., Zitman F.G., DeRijk R.H., Wüst S. Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone. Psychoneuroendocrinology 2010, 35:339-349. 10.1016/j.psyneuen.2009.07.006
139. van Leeuwen N., Bellingrath S., de Kloet E.R., Zitman F.G., DeRijk R.H., Kudielka B.M., Wüst S., Wust S. Human mineralocorticoid receptor (MR) gene haplotypes modulate MR expression and transactivation: implication for the stress response. Psychoneuroendocrinology 2011, 36:699-709. 10.1016/j.psyneuen.2010.10.003
140. Vogel S., Gerritsen L., van Oostrom I., Arias-Vasquez A., Rijpkema M., Joëls M., Franke B., Tendolkar I., Fernandez G. Linking genetic variants of the mineralocorticoid receptor and negative memory bias: interaction with prior life adversity. Psychoneuroendocrinology 2014, 40:181-190. 10.1016/j.psyneuen.2013.11.010
141. Wang S.-S., Kamphuis W., Huitinga I., Zhou J.-N., Swaab D.F. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol. Psychiatry 2008, 13:786-799. 741. 10.1038/mp.2008.38
142. Watzka M., Beyenburg S., Blümcke I., Elger C.E., Bidlingmaier F., Stoffel-Wagner B. Expression of mineralocorticoid and glucocorticoid receptor mRNA in the human hippocampus. Neurosci. Lett. 2000, 290:121-124.
143. Wellhoener P., Born J., Fehm H.L., Dodt C. Elevated resting and exercise-induced cortisol levels after mineralocorticoid receptor blockade with canrenoate in healthy humans. J. Clin. Endocrinol. Metab. 2004, 89:5048-5052. 10.1210/jc.2004-0086
144. Wingenfeld K., Wolf O.T. HPA axis alterations in mental disorders: impact on memory and its relevance for therapeutic interventions. CNS Neurosci. Ther. 2011, 17:714-722. 10.1111/j.1755-5949.2010.00207.x
145. Wingenfeld K., Kuehl L.K., Janke K., Hinkelmann K., Dziobek I., Fleischer J., Otte C., Roepke S. Enhanced emotional empathy after mineralocorticoid receptor stimulation in women with borderline personality disorder and healthy women. Neuropsychopharmacology 2014, 39:1799-1804. 10.1038/npp.2014.36
146. Workel J.O., Oitzl M.S., Fluttert M., Lesscher H., Karssen A., de Kloet E.R. Differential and age-dependent effects of maternal deprivation on the hypothalamic-pituitary-adrenal axis of Brown Norway rats from youth to senescence. J. Neuroendocrinol. 2001, 13:569-580. 10.1046/j.1365-2826.2001.00668.x
147. Wu T.C., Chen H.T., Chang H.Y., Yang C.Y., Hsiao M.C., Cheng M.L., Chen J.C. Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior. Psychoneuroendocrinology 2013, 38:871-883. 10.1016/j.psyneuen.2012.09.011
148. Wyrwoll C.S., Holmes M.C., Seckl J.R. 11β-Hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress. Front. Neuroendocrinol. 2011, 32:265-286. 10.1016/j.yfrne.2010.12.001
149. Xing G.-Q., Russell S., Webster M.J., Post R.M. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder. Int. J. Neuropsychopharmacol. 2004, 7:143-153. 10.1017/S1461145703004000
150. Yau J.L.W., Olsson T., Morris R.G.M., Meaney M.J., Seckl J.R. Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats. Neuroscience 1995, 66:571-581. 10.1016/0306-4522(94)00612-9
151. Yau J.L.W., Noble J., Hibberd C., Seckl J.R. Short-term administration of fluoxetine and venlafaxine decreases corticosteroid receptor mRNA expression in the rat hippocampus. Neurosci. Lett. 2001, 306:161-164. 10.1016/S0304-3940(01)01890-0
152. Yau J.L.W., Hibberd C., Noble J., Seckl J.R. The effect of chronic fluoxetine treatment on brain corticosteroid receptor mRNA expression and spatial memory in young and aged rats. Brain Res. Mol. Brain Res. 2002, 106:117-123.
153. Yau J.L.W., Noble J., Hibberd C., Rowe W.B., Meaney M.J., Morris R.G.M., Seckl J.R. Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats. J. Neurosci. 2002, 22:1436-1442. http://www.jneurosci.org/content/22/4/1436.full
154. Yau J.L.W., Seckl J.R. Local amplification of glucocorticoids in the aging brain and impaired spatial memory. Front. Aging Neurosci. 2012, 29:24. 10.3389/fnagi.2012.00024
155. Young E.A., Lopez J.F., Murphy-Weinberg V., Watson S.J., Akil H. The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans. J. Clin. Endocrinol. Metab. 1998, 83:3339-3345. 10.1210/jcem.83.9.5077
156. Young E.A., Lopez J.F., Murphy-Weinberg V., Watson S.J., Akil H. Mineralocorticoid receptor function in major depression. Arch. Gen. Psychiatry 2003, 60:24-28. 10.1001/archpsyc.60.1.24
157. Zhou M., Kindt M., Joëls M., Krugers H.J. Blocking mineralocorticoid receptors prior to retrieval reduces contextual fear memory in mice. PLoS ONE 2011, 6:e26220. 10.1371/journal.pone.0026220
158. Zobel A.W., Yassouridis A., Frieboes R.M., Holsboer F. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. Am. J. Psychiatry 1999, 156:949-951.